-
EP3470055
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3470055
| EP3470055 - INTRAVAGINAL DRUG DELIVERY DEVICES FOR THE DELIVERY OF MACROMOLECULES AND WATER-SOLUBLE DRUGS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 22.09.2023 Database last updated on 14.06.2024 | |
| Former | Examination is in progress Status updated on 13.01.2023 | ||
| Former | Request for examination was made Status updated on 25.10.2019 | ||
| Former | The application has been published Status updated on 15.03.2019 | Most recent event Tooltip | 22.09.2023 | Application deemed to be withdrawn | published on 25.10.2023 [2023/43] | Applicant(s) | For all designated states Allergan Pharmaceuticals International Limited Clonshaugh Industrial Estate Coolock Dublin 17 / IE | [2019/16] | Inventor(s) | 01 /
WOOLFSON, Aaron, David 17 Bristow Park Belfast, Antrim BT9 6TF / GB | 02 /
MALCOLM, Karl 3 Briarwood Park Gilnahirk Belfast, Antrim BT5 7HZ / GB | [2019/16] | Representative(s) | FRKelly Waterways House Grand Canal Quay Dublin D02 PD39 / IE | [N/P] |
| Former [2019/16] | FRKelly 27 Clyde Road Dublin D04 F838 / IE | Application number, filing date | 18190094.5 | 26.06.2008 | [2019/16] | Priority number, date | US20070946299P | 26.06.2007 Original published format: US 946299 P | [2019/16] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3470055 | Date: | 17.04.2019 | Language: | EN | [2019/16] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 20.03.2019 | Classification | IPC: | A61K9/00, A61K38/00, A61K39/00, A61K48/00, A61K39/12, A61K39/21, C07K16/10, C07K14/00 | [2019/16] | CPC: |
A61K9/0036 (EP,CN,US);
A61K31/00 (EP,US);
A61K31/185 (CN);
A61K39/12 (EP,US);
A61K39/21 (EP,US);
A61K39/395 (CN);
A61K45/06 (CN);
A61K47/24 (CN);
A61K47/34 (CN);
A61M31/002 (CN);
A61P31/18 (EP);
C07K14/005 (EP,US);
C07K16/1063 (EP,US);
A61K2039/541 (EP,US);
C12N2740/16034 (EP,US);
C12N2740/16122 (EP,US)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2019/48] |
| Former [2019/16] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR | Title | German: | VORRICHTUNGEN ZUR INTRAVAGINALEN AUSGABE VON MAKROMOLEKÜLEN UND WASSERLÖSLICHEN ARZNEIMITTELN | [2019/16] | English: | INTRAVAGINAL DRUG DELIVERY DEVICES FOR THE DELIVERY OF MACROMOLECULES AND WATER-SOLUBLE DRUGS | [2019/16] | French: | DISPOSITIFS D'ADMINISTRATION INTRAVAGINALE DE MÉDICAMENTS POUR L'ADMINISTRATION DE MACROMOLÉCULES ET DE MÉDICAMENTS HYDROSOLUBLES | [2019/16] | Examination procedure | 17.10.2019 | Amendment by applicant (claims and/or description) | 17.10.2019 | Examination requested [2019/48] | 17.10.2019 | Date on which the examining division has become responsible | 16.01.2023 | Despatch of a communication from the examining division (Time limit: M04) | 27.05.2023 | Application deemed to be withdrawn, date of legal effect [2023/43] | 20.06.2023 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2023/43] | Parent application(s) Tooltip | EP08772073.6 / EP2170276 | Fees paid | Renewal fee | 18.09.2018 | Renewal fee patent year 03 | 18.09.2018 | Renewal fee patent year 04 | 18.09.2018 | Renewal fee patent year 05 | 18.09.2018 | Renewal fee patent year 06 | 18.09.2018 | Renewal fee patent year 07 | 18.09.2018 | Renewal fee patent year 08 | 18.09.2018 | Renewal fee patent year 09 | 18.09.2018 | Renewal fee patent year 10 | 18.09.2018 | Renewal fee patent year 11 | 27.06.2019 | Renewal fee patent year 12 | 29.06.2020 | Renewal fee patent year 13 | 28.06.2021 | Renewal fee patent year 14 | 31.03.2022 | Renewal fee patent year 15 | 31.03.2023 | Renewal fee patent year 16 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO9804220 (POPULATION COUNCIL INC [US]) [X] 1-15 * figures 3,4 * * claims 1-34 ** page 9, line 4 - page 23, line 26 *; | [X]WO0113780 (FEI TECHNOLOGIES INC [US]) [X] 1-15 * figures 7,9 * * claims 1-43 * * page 13, line 21 - page 18, line 28 * * page 22, line 16 - page 27, line 6 * | by applicant | US5855906 | US5972372 | US6126958 | WO0170154 | US6436428 | - M. KAJIHARA et al., J. Cont. Rel., (20000000), vol. 66, pages 49 - 61 | - M. KAJIHARA et al., J. Cont. Rel., (20010000), vol. 73, pages 279 - 291 | - J.M. KEMP et al., Vaccine, (20020000), vol. 20, pages 1089 - 1098 | - S.A. LOFTHOUSE et al., Vaccine, (20020000), vol. 20, pages 1725 - 1732 | - M. MAEDA et al., J. Cont. Rel., (20020000), vol. 84, pages 15 - 25 | - H. MAEDA et al., Int'l. J. Pharm., (20030000), vol. 261, pages 9 - 19 | - M. KAJIHARA et al., Chem. Pharm. Bull., (20030000), vol. 51, pages 15 - 19 | - H. MAEDA et al., J. Cont. Rel., (20030000), vol. 90, pages 59 - 70 | - T. M. JACKANICZ, Vaginal Contraception: New Developments, Harper and Row, (19790000), pages 201 - 212 | - ROUMEN et al., Contraception, (19990000), vol. 59, pages 59 - 62 | - VARTIAINEN et al., Maturitas, (19930000), vol. 17, pages 129 - 137 |